Nuvectis Pharma, Inc. (NASDAQ:NVCT) insiders have significant skin in the game with 67% ownership [Yahoo! Finance]
Nuvectis Pharma, Inc. (NVCT)
Company Research
Source: Yahoo! Finance
Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company If you want to know who really controls Nuvectis Pharma, Inc. ( NASDAQ:NVCT ), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are individual insiders with 67% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company. With such a notable stake in the company, insiders would be highly incentivised to make value accretive decisions. Let's delve deeper into each type of owner of Nuvectis Pharma, beginning with the chart below. Check out our latest analysis for Nuvectis Pharma What Does The Institutional Ownership Tell Us About Nuvectis Pharma? Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices. As y
Show less
Read more
Impact Snapshot
Event Time:
NVCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVCT alerts
High impacting Nuvectis Pharma, Inc. news events
Weekly update
A roundup of the hottest topics
NVCT
News
- Wall Street Analysts See a 229.34% Upside in Nuvectis Pharma (NVCT): Can the Stock Really Move This High? [Yahoo! Finance]Yahoo! Finance
- Nuvectis Pharma: An Interesting Early Pipeline Does Not Justify A Buy [Seeking Alpha]Seeking Alpha
- Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference [Yahoo! Finance]Yahoo! Finance
- Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor ConferenceGlobeNewswire
- Nuvectis Pharma, Inc. (NASDAQ: NVCT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.MarketBeat
NVCT
Earnings
- 5/7/24 - Beat
NVCT
Analyst Actions
- 5/8/24 - HC Wainwright
NVCT
Sec Filings
- 5/15/24 - Form 4
- 5/13/24 - Form 4
- 5/13/24 - Form 4
- NVCT's page on the SEC website